Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease

              Author:Scheltens, Philip   Atri, Alireza   Feldman, Howard   Hansson, Oskar   Knop, Filip   Sano, Mary   Dethlefsen, Claus   Johannsen, Peter   León, Teresa   Hansen, Charlotte Thim   Cummings, Jeffrey   

              Session Name:P11: Dementia and Behavioral Neurology: Treatments 2  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:P11.013  

              Author Institution:VU University Medical Center Amsterdam, Amsterdam, Netherlands  Banner Sun Health Research Institute  Banner Alzheimer’s Institute  Brigham and Women’s Hospital, Harvard Medical School , Sun City, AZ  University of California San Diego, La Jolla, CA  Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University  Memory Clinic, Skåne University Hospital, Lund, Sweden  Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen  Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen  Steno Diabetes Center Copenhagen  Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Hellerup, Denmark  Icahn School of Medicine at Mount Sinai, James J Peters VAMC , Bronx, NY  Novo Nordisk A/S, Søborg, Denmark  Novo Nordisk A/S, Madrid, Spain  University of Nevada, Henderson, NV